2,723 results match your criteria: "Canadian Center for Behavioural Neuroscience; University of Lethbridge[Affiliation]"
Neurosci Biobehav Rev
July 2025
Department of Cell & Systems Biology, University of Toronto, Toronto, ON, Canada.
Microdosing, the repeated use of psychedelic substances at low doses, is growing in popularity among recreational consumers. While this practice is associated with many benefits to mood, well-being and health, research in this area is in its early stages and predominantly centered on human applications. In this narrative review, we synthesize the findings from studies investigating the effects of microdosing on the behaviors of three animal species: rats, mice, and zebrafish.
View Article and Find Full Text PDFJ Gambl Stud
September 2025
Department of Sociology and Anthropology, Concordia University, 1455 de Maisonneuve Blvd. W, Montreal, QC, H2G 1M8, Canada.
The Problem Gambling Severity Index (PGSI) is a popular tool for assessing past-year problems related to gambling. Multiple categorization schemes have been proposed, with scores 3-7 variously interpreted as reflecting a 'moderate' degree of problems. Crucially, it is possible to land in this Moderate-risk category by reporting one or two persistent problems, or up to seven problems that occur more sporadically.
View Article and Find Full Text PDFPsychedelic Med (New Rochelle)
March 2025
University of Toronto, Toronto, Canada.
Background: Bipolar II disorder (BD-II) is often associated with chronic and treatment resistant major depressive episodes. Psilocybin has shown promise for its rapid-acting antidepressant effects, though its impact on bipolar depression remains unexplored. In the present subgroup analysis of an already published trial on treatment-resistant depression (TRD), we aimed to preliminarily evaluate the safety and efficacy of psilocybin in patients with BD-II.
View Article and Find Full Text PDFJAMA Psychiatry
July 2025
Hampshire and Isle of Wight Healthcare National Health Service Foundation Trust, Southampton, United Kingdom.
Importance: Representation of race and ethnicity in randomized clinical trials (RCTs) is critical for understanding treatment efficacy across populations with different racial and ethnic backgrounds.
Objective: To examine race and ethnicity representation and reporting across RCTs of pharmacotherapies for mental disorders.
Data Sources: PubMed (Medline), Embase (Ovid), APA PsycInfo, and Web of Science were searched until March 1, 2024, to retrieve network meta-analyses including RCTs of pharmacotherapies for International Statistical Classification of Diseases and Related Health Problems, Tenth Revision mental disorders.
Ear Hear
August 2025
Department of Neuroscience, Canadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, Alberta, Canada.
Objectives: Despite the extensive use of machine learning (ML) models in health sciences for outcome prediction and condition classification, their application in differentiating various types of auditory disorders remains limited. This study aimed to address this gap by evaluating the efficacy of five ML models in distinguishing (a) individuals with tinnitus from those without tinnitus and (b) noise-induced hearing loss (NIHL) from age-related hearing loss (ARHL).
Design: We used data from a cross-sectional study of the Canadian population, which included audiologic and demographic information from 928 adults aged 30 to 100 years, diagnosed with either ARHL or NIHL due to long-term occupational noise exposure.
PLoS One
May 2025
Department of Psychiatry & Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Introduction: Child maltreatment is prevalent in Canada; how we measure it varies. The objective of the current study was to examine the psychometric properties of the Childhood Experiences of Violence Questionnaire Short Form (CEVQ-SF) physical and sexual abuse measures and of the Canadian Community Health Survey (CCHS) 2-item sexual abuse measure, compared with the Childhood Trauma Questionnaire (CTQ) in two samples of adolescents and young adults.
Methods: Retrospective, self-reported child abuse history was collected in the British Columbia Healthy Connections Project (BCHCP) and in the Well-Being and Experiences (WE) Study.
J Subst Use Addict Treat
August 2025
Interventional Psychiatry Program, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: venkat.bhat@
Background And Aims: Substance Use Disorders (SUDs) involve diminished control, risky use, impaired social interactions, and physical dependence. Despite their global prevalence and burden, treatment options remain limited. Ketamine (KET), an NMDA receptor antagonist, may aid SUD treatment by modulating glutamatergic neurotransmission.
View Article and Find Full Text PDFSoc Psychiatry Psychiatr Epidemiol
April 2025
Department of Applied Psychology and Human Development, University of Toronto, Toronto, ON, Canada.
Purpose: This study examined how pre-existing early-life adversity (ELA) and current social support interacted with COVID-specific pandemic stressors in relation to risk of psychiatric disorders in a nationally-representative sample of Canadian adults.
Methods: Participants (n = 9,409) were from the Mental Health and Access to Care Survey, a cross-sectional survey of Canadian adults during later stages of the COVID pandemic (March to July 2022). Measures included pandemic stressors (Statistics Canada), ELA (Childhood Experiences of Violence Questionnaire), social support (Social Provisions Scale), and past 12-month psychiatric problems (WHO-CIDI).
Can J Psychiatry
July 2025
Department of Psychiatry, Dalhousie University, Halifax, Canada.
BackgroundRelapse rates in major depressive disorder (MDD) remain high even after treatment to remission. Identifying predictors of relapse is, therefore, crucial for improving maintenance strategies and preventing future episodes. Remote data collection and sensing technologies may allow for more comprehensive and longitudinal assessment of potential predictors.
View Article and Find Full Text PDFSci Rep
April 2025
Faculty of Kinesiology, University of New Brunswick, Fredericton, NB, Canada.
This study aimed to estimate the effects of preoperative psychological health on postoperative outcomes in patients undergoing surgery for cervical spondylotic radiculopathy. This retrospective cohort study included data from patients enrolled in the Canadian Spine Outcomes and Research Network who underwent anterior cervical discectomy and fusion for radiculopathy. Preoperative psychological health was measured with the Patient Health Questionnaire-8 (PHQ-8), and depression and severe psychological symptomology were measured with the Mental Component Score of the Short Form Survey-12 (MCS).
View Article and Find Full Text PDFJ Trauma Stress
August 2025
MacDonald Franklin OSI Research and Innovation Centre, Lawson Research Institute, London, Ontario, Canada.
Anger is a natural, adaptive emotion that is culturally accepted in military settings. Problematic anger (i.e.
View Article and Find Full Text PDFPharmaceutics
March 2025
Interventional Psychiatry Program, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.
Psilocybin has shown promise in therapeutic applications for mental disorders. Understanding the pharmacokinetics of psilocybin and its active metabolite psilocin is crucial for optimizing its clinical use and minimizing adverse effects. This systematic review involved a comprehensive search across MEDLINE, APA PsycINFO, and Embase databases, from inception to December 2024, identifying original studies that investigated the pharmacokinetics of psilocybin.
View Article and Find Full Text PDFInt Psychogeriatr
April 2025
Neuropsychopharmacology Research Group, Toronto, ON, Canada; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, Temerty Faculty of Medicine, University of T
Background: Diagnostic criteria for apathy in neurocognitive disorders (DCA-NCD) have recently been updated.
Objectives: We investigated whether validated scales measuring apathy severity capture the three dimensions of the DCA-NCD (diminished initiative, diminished interest, diminished emotional expression).
Measurements: Degree of mapping ("not at all", "weakly", or "strongly") between items on two commonly used apathy scales, the Neuropsychiatric Inventory-Clinician (NPI-C) apathy and Apathy Evaluation Scale (AES), with the DCA-NCD overall and its 3 dimensions was evaluated by survey.
Alzheimers Dement
April 2025
Krembil Research Institute, University Health Network, Toronto, Canada.
Introduction: Higher male prevalence in sporadic behavioral variant frontotemporal dementia (bvFTD) has been reported. We hypothesized differences in phenotypes between genetic and sporadic bvFTD females resulting in underdiagnosis of sporadic bvFTD females.
Methods: We included genetic and sporadic bvFTD patients from two multicenter cohorts.
EBioMedicine
May 2025
Division of Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Germany; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany. Electronic address:
Background: While most sporadic adult-onset neurodegenerative diseases have only a minor monogenic component, given several recently identified late adult-onset ataxia genes, the genetic burden may be substantial in sporadic adult-onset ataxias. We report systematic mapping of the genetic landscape of sporadic adult-onset ataxia in a well-characterised, multi-centre cohort, combining several multi-modal genetic screening techniques, plus longitudinal natural history data.
Methods: Systematic clinico-genetic analysis of a prospective longitudinal multi-centre cohort of 377 consecutive patients with sporadic adult-onset ataxia (SPORTAX cohort), including clinically defined sporadic adult-onset ataxia of unknown aetiology (SAOA) (n = 229) and 'clinically probable multiple system atrophy of cerebellar type' (MSA-C) (n = 148).
Mol Brain
April 2025
Center for Advanced Research in Sleep Medicine, Recherche CIUSSS-NIM, Montréal, Canada.
Associated to glutamatergic neurotransmission, Neuroligin-1 (NLGN1) is a synaptic adhesion molecule with roles in the regulation of behavioral states and cognitive function. It was shown to shape electrocorticographic (ECoG) activity during wakefulness and sleep in male mice, including aperiodic activity under baseline conditions. Given that the expression of Neuroligins (Nlgn) differs between sexes, we here aim to characterize the impact of the absence of NLGN1 on the wakefulness and sleep architecture, rhythmic and arrhythmic activity dynamics, and responses to sleep deprivation in female animals.
View Article and Find Full Text PDFNature
May 2025
School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland.
Environmental thermal challenges trigger the brain to coordinate both autonomic and behavioural responses to maintain optimal body temperature. It is unknown how temperature information is precisely stored and retrieved in the brain and how it is converted into a physiological response. Here we investigated whether memories could control whole-body metabolism by training mice to remember a thermal challenge.
View Article and Find Full Text PDFNPJ Parkinsons Dis
April 2025
Western Centre for Brain and Mind, Western University, London, ON, Canada.
Idiopathic REM sleep behaviour disorder (iRBD) is considered a prodromal form of Parkinson's Disease (PD), potentially exhibiting similar patterns of neurodegeneration, such as brain iron changes. We investigated midbrain and pallidal iron using quantitative susceptibility mapping (QSM) in 16 iRBD patients, 30 PD patients, and 38 age-matched healthy controls (HCs) with 3T MRI. QSM revealed elevated substantia nigra pars compacta (SNc) mean susceptibility in both iRBD and PD patient groups compared to HCs, though iRBD and PD QSM measures did not differ.
View Article and Find Full Text PDFJAMA Netw Open
April 2025
Peter Boris Centre for Addictions Research, St Joseph's Healthcare Hamilton. Hamilton, Ontario, Canada.
Importance: An increasing number of jurisdictions have legalized recreational cannabis for adults, but most evaluations have used repeated cross-sectional designs, preventing examination of within-person and subgroup trajectories across legalization.
Objective: To examine changes in cannabis use and misuse in the 5 years following legalization in Canada both overall and by prelegalization cannabis use frequency using a longitudinal design.
Design, Setting, And Participants: This prospective cohort study included data from community-dwelling adults who participated in up to 11 biannual assessments from September 2018 to October 2023 in Ontario, Canada.
BMJ Open
April 2025
Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Introduction: Concussion affects over 400 000 Canadians annually, with a range of causes and impacts on health-related quality of life. Research to date has disproportionately focused on athletes, military personnel and level I trauma centre patients, and may not be applicable to the broader community. The TRANSCENDENT Concussion Research Program aims to address patient- and clinician-identified research priorities, through the integration of clinical data from patients of all ages and injury mechanisms, patient-reported outcomes and objective biomarkers across factors of intersectionality.
View Article and Find Full Text PDFHealth Rep
April 2025
Health Analysis Division, Statistics Canada.
Background: It is not clear whether the increased mortality pattern observed in a prior analysis of the Canadian Census Health and Environment Cohorts for HIV/AIDS, diabetes, prostate cancer, and uterine cancer among Black adults is reflected in incident hospitalization (a marker of severity) or the diagnosis of these diseases, nor is it clear whether disparities exist regarding early screening and survivability.
Methods: To understand the paths that contribute to differential mortality patterns, standard Cox proportional hazard models were used to assess the incidence risk of diagnosis (uterine and prostate cancer) and incident hospitalization (HIV and diabetes) among 161,520 Black adults, compared with 6,866,070 White adults. Competing risk regression was used to evaluate the cumulative risk of death for the four disease outcomes since diagnosis or hospitalization.
Brain
August 2025
Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON M4N 3M5, Canada.
Common variants within TMEM106B are associated with risk for frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP). The G allele of the top single nucleotide polymorphism, rs1990622, confers protection against FTLD-TDP, including genetic cases due to GRN mutations or C9orf72 hexanucleotide repeat expansions. However, the effects of interaction between TMEM106B-rs1990622 and frontotemporal dementia (FTD) mutations on disease endophenotypes in genetic FTD are unknown.
View Article and Find Full Text PDFNat Neurosci
June 2025
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Genome-wide enrichment of gene-specific tandem repeat expansions has been linked to autism spectrum disorder. One such mutation is the CTG tandem repeat expansion in the 3' untranslated region of the DMPK gene, which is known to cause myotonic muscular dystrophy type 1. Although there is a clear clinical association between autism and myotonic dystrophy, the molecular basis for this connection remains unknown.
View Article and Find Full Text PDFBMJ Evid Based Med
April 2025
Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Neurology
May 2025
Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Background And Objectives: Disturbances in brain catecholamine activity may be associated with symptoms after exposure to repetitive head impacts (RHIs) or related chronic traumatic encephalopathy (CTE). In this article, we studied CSF catecholamines in former professional and college American football players and examined the relationship with football proxies of RHI exposure, CTE probability, cognitive performance, neuropsychiatric symptoms, and parkinsonism.
Methods: In this observational cross-sectional study, we examined male former American football players, professional ("PRO") or college ("COL") level, and asymptomatic unexposed male ("UE") individuals from the DIAGNOSE CTE Research Project.